Diabetes Management for Nurses: Insulin Types, Sliding Scales, and Hypoglycemia Response

Every insulin question on the NCLEX and in clinical practice comes down to knowing four categories and their timing profiles: rapid-acting, short-acting, intermediate-acting, and long-acting. The timing profile — onset, peak, and duration — tells you when the insulin starts working, when it is working hardest, and when it stops. Rapid-acting insulins (lispro/Humalog, aspart/NovoLog, glulisine/Apidra) have onset in 10-15 minutes, peak at 1-2 hours, and duration of 3-5 hours. These are given immediately before or with meals. The critical nursing point: if you give rapid-acting insulin and the patient does not eat, they will become hypoglycemic. Always verify the food tray has arrived before administering. Short-acting insulin (regular/Humulin R, Novolin R) has onset in 30-60 minutes, peak at 2-4 hours, and duration of 5-8 hours. Regular insulin is the only insulin that can be given IV — this is high-yield for NCLEX. It is given 30 minutes before meals when used for mealtime coverage. Regular insulin is also the basis for most sliding scale protocols. Intermediate-acting insulin (NPH/Humulin N, Novolin N) has onset in 1-2 hours, peak at 4-12 hours (this wide peak window is clinically important), and duration of 18-24 hours. NPH is cloudy — it must be gently rolled (never shaken) to resuspend the crystals. The prolonged peak means patients are at risk for hypoglycemia hours after administration, particularly in the late afternoon (for morning doses) or early morning (for evening doses). Long-acting insulins (glargine/Lantus/Basaglar, detemir/Levemir, degludec/Tresiba) provide a relatively flat, peakless basal insulin level for 20-24+ hours. Glargine is given once daily at the same time each day. It cannot be mixed with any other insulin in the same syringe — the acidic pH (which keeps it in solution) will alter other insulins. Long-acting insulin provides the background insulin level; mealtime rapid or short-acting covers the glucose spikes from eating.

Insulin administration errors are among the most common and most dangerous medication errors in hospitals. The details matter enormously. Always use insulin-specific syringes calibrated in units. Never draw insulin into a standard syringe — the volume markings do not correspond to insulin units and you will administer the wrong dose. For IV insulin, use a dedicated infusion pump with an insulin-specific protocol. Site rotation: rotate injection sites within the same anatomical region (e.g., all abdominal injections but moving to a different spot each time) rather than jumping between regions. Absorption rates differ by site — abdomen is fastest, then arms, then thighs, then buttocks. Jumping between regions changes the onset and peak timing unpredictably. Lipohypertrophy (lumpy fatty deposits from repeated injections in the same spot) reduces absorption — always inspect injection sites and avoid injecting into hypertrophied tissue. Mixing insulins: when drawing two insulins into the same syringe (e.g., NPH and Regular), always draw the clear insulin first, then the cloudy insulin. The mnemonic is clear before cloudy or RN (Regular before NPH). The reason: if you contaminate the regular vial with NPH, you have unpredictable intermediate-acting insulin in your regular vial. Never mix long-acting insulin (glargine, detemir) with any other insulin. Timing relative to meals is critical. Rapid-acting insulin should be given within 15 minutes of eating — ideally as the tray arrives. If the patient is NPO, hold the mealtime insulin and notify the provider. Basal (long-acting) insulin is generally still given even when NPO because it covers the body's baseline glucose production, but always verify with the specific order.

A sliding scale is a set of pre-written orders that tells you how much additional insulin to give based on the patient's current blood glucose reading. It provides a reactive correction — it does not replace basal or mealtime insulin. Most sliding scales use Regular or rapid-acting insulin. A typical sliding scale might look like this: BG 70-150 = 0 units, BG 151-200 = 2 units, BG 201-250 = 4 units, BG 251-300 = 6 units, BG 301-350 = 8 units, BG above 350 = 10 units and notify provider. The specific numbers vary by patient and provider — always use the exact scale ordered for your patient. The nursing responsibility: check blood glucose at the ordered times (typically before meals and at bedtime), identify the correct range on the scale, administer the corresponding dose, and document everything. If the blood glucose is below 70, do not give insulin — treat the hypoglycemia instead. If the glucose is critically high (above the scale range), notify the provider before administering. Common sliding scale pitfalls: giving the correction dose without checking if the patient has also received their scheduled mealtime insulin (risk of stacking), failing to recheck glucose after administering correction insulin, and not recognizing that a patient consistently needing large correction doses needs their basal regimen adjusted — the sliding scale is a bandage, not a long-term solution. NurseIQ includes practice scenarios where you must interpret sliding scale orders, calculate correction doses, and make clinical judgment calls about when to hold insulin or escalate to the provider.

Hypoglycemia (blood glucose below 70 mg/dL) is the most dangerous acute complication of insulin therapy and requires immediate nursing intervention. Recognition must be rapid because the brain depends on glucose and damage occurs within minutes of severe hypoglycemia. Mild symptoms (BG 54-70): tremors, diaphoresis, tachycardia, anxiety, hunger, pallor, tingling around the mouth. These are adrenergic symptoms — the body's catecholamine response to falling glucose. The patient is usually alert and able to self-treat. Moderate symptoms (BG 40-54): confusion, difficulty concentrating, slurred speech, blurred vision, irritability, mood changes, poor coordination. These are neuroglycopenic symptoms — the brain is not getting enough glucose to function normally. The patient may need assistance. Severe symptoms (BG below 40): loss of consciousness, seizures, inability to swallow. This is a medical emergency requiring IV dextrose or IM glucagon. The Rule of 15 for conscious patients who can swallow: give 15 grams of fast-acting carbohydrate (4 oz juice, 4 oz regular soda, 3-4 glucose tablets, or 1 tablespoon honey). Wait 15 minutes and recheck blood glucose. If still below 70, repeat with another 15 grams. Once glucose is above 70, give a small snack with protein and complex carbohydrate to prevent recurrence. The reason for 15 grams specifically: it raises blood glucose approximately 30-45 mg/dL within 15 minutes without overshooting into hyperglycemia. For unconscious patients or those who cannot swallow safely: administer IV dextrose 50% (D50) 25 mL push (12.5 grams of glucose) per protocol, or IM glucagon 1 mg if no IV access. Turn the patient on their side to prevent aspiration. Never attempt to give oral glucose to an unconscious patient — aspiration risk is immediate and life-threatening. This content is for educational purposes only and does not constitute medical advice.